Adaptogenics Health Corp. is a listed company. Its directors and officers file their transactions with SEDI. The last twelve months, up to 18 October 2026, brought 10 filings signed by 5 insiders.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
For context, the typical company on the same exchange (median of 2,130 companies) published 12 filings over the same period, against 10 filings here.
Insider buying of Adaptogenics Health Corp. has been absent for the past year. Filings reach the SEDI feed a median of 30 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done.
Source: insider filings from SEDI. Past trades are no guide to future returns.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
10 of 10 declarations
Adaptogenics Health Corp. is a company listed on the XTSE, specializing in the development of health products based on adaptogens. It focuses on innovation in the nutritional supplements sector.
Insider filings
Over the last 90 days, 10 filings published between 28 September and 7 October 2026: no open-market purchase or sale filed by an insider. 10 other filings (not open-market purchases or sales: grants, options, plans, sale notices, block transfers).
Summary written automatically from public filings, without human review. General information, identical for every reader: it is not investment advice or a recommendation to buy or sell. Investing involves a risk of capital loss. Generated on 14 October 2026 (UTC)